NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...
The American Heart Association is highlighting the importance of continuous care for individuals with congenital heart ...
VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...
Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...
Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...
Zacks.com on MSN5d
Medtronic Stock Trading at a Discount Before Q2 Earnings: Time to Buy?Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...
England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.
Remote patient monitoring platform Wanda announced a strategic partnership ... Novo Nordisk’s Wegovy helped heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback